Advertisement
News
Subscribe to MDT Magazine News

Using Technology to Maximize the Clinician's Role

January 26, 2011 6:33 am | by Diagnostic Imaging | Comments

The iPad and other mobile devices are able to provide access to an enormous amount of information quickly. When combined with the knowledge and expertise of a skilled professional such as a doctor, these tools are amplified in their efficiency. With an iPad, every physician can become an...

TOPICS:

New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

ALBUQUERQUE, N.M., Jan. 26, 2011 /- New Mexico Software, Inc. (OTC Bulletin Board: NMXC ), a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the implementation of a software module that gives the...

TOPICS:

QPS Expands Phase 1 and Bioanalytical Capability by Acquisition of Bioserve, India

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

NEWARK, Del. and HYDERABAD, India, Jan. 26, 2011 /- QPS, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the acquisition of a majority stake in Bioserve Clinical...

TOPICS:
Advertisement

MedCath Corporation to Release First Quarter Results

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

CHARLOTTE, N.C., Jan. 26, 2011 /- MedCath Corporation (Nasdaq: MDTH ) will issue a press release after the market closes on February 9, 2011 to announce results from its first fiscal quarter ended December 31, 2010. MedCath has elected not to host a conference call to review its first...

TOPICS:

Avantra Biosciences Launches Multiplex System for Faster, Easier Quantification of Cancer Protein Biomarkers

January 26, 2011 6:32 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Jan. 26, 2011 /- Avantra® Biosciences, a leading innovator in protein diagnostics, announced today their first shipments of the new Q400 Biomarker Workstation and the innovative Angio Qx™ BioChip Immunoassay. The system provides quantitative protein biomarker...

TOPICS:

Research shows how pathogenic bacteria hide inside host cells

January 26, 2011 5:31 am | by EurekAlert | Comments

(Wiley-Blackwell) A new study into Staphylococcus aureus, the bacterium which is responsible for severe chronic infections worldwide, reveals how bacteria have developed a strategy of hiding within host cells to escape the immune system as well as many antibacterial treatments. The...

TOPICS:

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Elementâ„¢ Everolimus-Eluting Stent

January 26, 2011 3:32 am | by Boston Scientific | Comments

PLATINUM China trial to support Chinese regulatory approval of next-generation platinum chromium stent

TOPICS:

STMicroelectronics Reports 2010 Fourth Quarter and Full Year Financial Results

January 26, 2011 2:33 am | by I-Micronews | Comments

?Fourth quarter net revenues increased 6.6% sequentially; 39.9% gross margin ?2010 net income of $830 million on highest ever net revenues of $10.35 billion ?Net financial position improved $732 million in 2010 to $1.15 billion* ?Record year for the full range of ST?s ?Sense and Power?...

Advertisement

WellPoint 4th-quarter net income drops

January 26, 2011 1:45 am | by The Associated Press | Comments

WellPoint says its fourth-quarter net income declined, as the prior-year period included a large gain related to a sale. Its adjusted results beat Wall Street's view.The largest publicly traded health insurer based on enrollment earned $548.8 million, or $1.40 per share, for the three months...

His Highness Sheikh Mohammed bin Zayed Al Nahyan and the Bill & Melinda Gates Foundation Partner to Immunize Children

January 26, 2011 1:34 am | by Bio-Medicine.Org | Comments

SEATTLE and ABU DHABI, United Arab Emirates, Jan. 26, 2011 /PRNewswire-USNewswire/ -- His Highness Sheikh Mohammed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, and Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation,...

TOPICS:

Global Genes Project Announces 'Wear That You Careâ„¢' Denim Awareness Campaign for Rare Disease Day 2011

January 26, 2011 1:33 am | by Bio-Medicine.Org | Comments

DANA POINT, Calif., Jan. 26, 2011 /- Monday, February 28, 2011, is the 4th annual Rare Disease Day — a day when people worldwide will show their support for the millions of people suffering from rare diseases and disorders.  According to statistics from the National Institutes...

TOPICS:

Arizona companies team up, providing quick development of cancer drugs

January 25, 2011 10:31 pm | by EurekAlert | Comments

(The Translational Genomics Research Institute) TGen Drug Development and Flagship Biosciences today announced a strategic alliance that should help speed new drugs safely into human testing and quickly benefit cancer patients.

TOPICS:

A Time-Lapse Movie Shot Inside the Brain

January 25, 2011 7:34 pm | by Massachusetts Institute of Technology | Comments

A tiny endoscope keeps watch over a particular spot in the brain as it develops, or degenerates with disease.

TOPICS:

Ohio to use assisted-suicide drug in executions

January 25, 2011 6:45 pm | by ANDREW WELSH-HUGGINS - AP Legal Affairs Writer - Associated Press | Comments

Ohio is set to become the first state to execute condemned inmates with a surgical sedative sometimes used in assisted suicides, a switch made as the shortage of the drug normally used for executions has worsened.Beginning in March, the state execution team will use a single, powerful dose of...

BioVex to be acquired by Amgen for up to $1 billion

January 25, 2011 4:37 pm | by Mass High Tech: The Journal of New England Technology | Comments

One of the original biotech stars, Amgen, has reached agreement to acquire Woburn-based BioVex Group Inc. for what could total $1 billion – $425 million in upfront cash and up to $575 million in additional payments based on regulatory and sales milestones.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading